- MDMA and psilocybin are reclassified as medicines for some mental health conditions in Australia.
- The TGA announced the changes on Friday, saying they would go into effect on July 1.
- Both drugs continue to be classified as prohibited substances.
The TGA ruling, announced Friday afternoon, sparked immediate and mixed reactions from medical researchers and academics.
“Perhaps most excitingly, many of the treatments emerging in these previously banned products require only brief exposures to facilitate treatment, blunt the edge of psychological trauma. You don’t need a lifelong prescription for the only drug you can get.
Certain psychiatrists are also allowed to prescribe psilocybin, the active ingredient in psychedelic mushrooms, for treatment-resistant depression. sauce: Getty / bloomberg creative
Dr. Paul Liknaitzky leads the Clinical Psychedelics Research Project at Monash University. This project is already providing psychedelic-assisted therapy to clinical patients.
“This schedule change is coming in a matter of months, so Australia has little time to figure this out.”
https://www.sbs.com.au/news/article/australia-will-reclassify-mdma-as-medicine-in-a-world-first-experts-have-mixed-views/9ja389o21 Australia will be the first country in the world to reclassify MDMA as a medicinal product.Expert opinion is mixed